| Released | Contributor | Author | Title | Pages | Price | | 30-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 | 569 |
$299 | | 30-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Health Care Industry Trends, Statistics & Analysis 2010 (Summary) | 98 |
$199 | | 30-Nov-2009 | New Constructs, LLC |
N/A
| GTCB: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings | 19 |
$10 | | 30-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Plunkett's Health Care Technologies Overview 2010 (Summary) | 80 |
$199 | | 30-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Health Care Industry Market Research and Competitive Analysis 2010 | 730 |
$299 | | 30-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) | 71 |
$199 | | 29-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for BIOTECHNOLOGY | 18 |
$49 | | 29-Nov-2009 | Wright Reports |
N/A
| Wright Investors Service Comprehensive Report for GTC Biotherapeutics, Inc. | 42 |
$65 | | 28-Nov-2009 | TheStreet.com Ratings |
N/A
| TheStreet.com Ratings Stock Report For: GTC BIOTHERAPEUTICS INC | 5 |
$25 | | 28-Nov-2009 | Standard & Poor's Quantitative Report |
N/A
| GTC Biotherapeutics | 5 |
$25 |
|
0.34% Nasdaq 
Research Reports
